Abstract
The aim of the QUASAR trial was to determine the size and duration of any survival benefit from adjuvant chemotherapy for patients with colorectal cancer at low risk of recurrence, for whom the indication for such treatment is unclear.
Original language | English |
---|---|
Pages (from-to) | 2020-2029 |
Number of pages | 10 |
Journal | Lancet |
Volume | 370 |
Issue number | 9604 |
DOIs | |
Publication status | Published - 15 Dec 2007 |
Keywords
- Adjuvants, Immunologic
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic
- Colorectal Neoplasms
- Combined Modality Therapy
- Female
- Fluorouracil
- Humans
- Leucovorin
- Levamisole
- Male
- Middle Aged
- Neoplasm Recurrence, Local
- Vitamin B Complex